These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 285686)

  • 21. Mood and behavioural changes with progestational agents.
    Kane FJ; Daly RJ; Ewing JA; Keeler MH
    Br J Psychiatry; 1967 Mar; 113(496):265-8. PubMed ID: 6029624
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on inhibitors of blood coagulation and fibrinolysis during use of oral contraceptives].
    Miyaji K
    Nihon Funin Gakkai Zasshi; 1982 Apr; 27(2):242-50. PubMed ID: 12158577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of blood coagulation parameters.
    Newman RL; Sirridge M; Brinkman M; Shannon R
    Am J Obstet Gynecol; 1976 May; 125(1):108-14. PubMed ID: 775991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of platelet inhibitors in migraine.
    Ryan RE; Ryan RE
    Adv Neurol; 1982; 33():247-52. PubMed ID: 7055003
    [No Abstract]   [Full Text] [Related]  

  • 26. Malignant hypertension with irreversible renal failure due to oral contraceptives.
    Zech P; Rifle G; Lindner A; Sassard J; Blanc-Brunat N; Traeger J
    Br Med J; 1975 Nov; 4(5992):326-7. PubMed ID: 1192051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cerebral venous thrombosis associated with the use of oral contraceptives].
    Tsuboi K; Maki Y; Kamezaki T; Kobayashi E; Meguro K
    No Shinkei Geka; 1986 Mar; 14(4):521-6. PubMed ID: 3713978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The probability of side effects with ovral, norinyl 1/50 and norlestrin.
    Berger GS; Edelman DA; Talwar PP
    Contraception; 1979 Nov; 20(5):447-53. PubMed ID: 160860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
    Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
    Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aorto-iliac occlusion in women using oral contraceptives. A report of 2 cases.
    Hall R; Bunch GA
    Br J Surg; 1971 Jul; 58(7):508-9. PubMed ID: 5089961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular side-effects of oral contraceptives.
    Radnót M; Follmann P
    Ann Clin Res; 1973 Aug; 5(4):197-204. PubMed ID: 4206444
    [No Abstract]   [Full Text] [Related]  

  • 33. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of contraceptive pills and intrauterine devices on urinary bladder.
    Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
    Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
    El Hakim SM; Abdin FH; Kandil O
    Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Femigen forte and mite preparations in contraception and gynecologival disorders].
    Sternadel Z; Pietrusiewicz W; Wasilewska B
    Ginekol Pol; 1970 Nov; 41(11):1227-36. PubMed ID: 4098877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transitory ischemic attacks, migraine and progestogen drugs. Etiopathogenetic correlations].
    Moretti G; Manzoni GC; Carpeggiani P; Parma M
    Minerva Med; 1980 Aug; 71(30):2125-9. PubMed ID: 7432644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation studies in women on combination type of oral contraceptives.
    Gupta K; Nain S; Manikeri S; Sheth UK; Vaidya P; Mandlekar A; Krishna UR
    J Obstet Gynaecol India; 1979 Jun; 29(3):647-9. PubMed ID: 12335923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.